Recruiting

Compilation and Preliminary Application of the Active Health Behavior Scale in Patients With Type 2 Diabetes

This study aims to develop the Active Health Behavior Scale for Type 2 Diabetes Mellitus (T2DM) patients and evaluate its psychometric properties, including internal consistency reliability, test-retest reliability, content validity, construct validity, and criterion-related validity. Additionally, this research will investigate the current status of active health behaviors among T2DM patients and employ latent profile analysis (LPA) to identify distinct behavioral subtypes. Furthermore, differences in…

ClinicalTrials.gov IDNCT07531459

PhaseNot Applicable

Enrollment600

SponsorYun Ye

Age18 Years

SexALL

I'm interested View official listing

Conditions studied

Type 2 Diabetes

About this study

Interventions

Other: Cross-sectional Study — In phase I, face-to-face semi-structured interviews will be conducted with approximately 15 patients with T2DM and 15 relevant healthcare workers (clinicians and nurses) from the Department of Endocrinology and Metabolism at the Third Affiliated Hospital of Soochow University. Each interview will last 15-30 minutes and take place in a quiet setting, such as an inpatient ward or demonstration classroom. In phase II (scale validation) and phase III (survey), T2DM patients attending the same department will be recruited.

Primary outcomes

Total scale score of the Active Health Behavior Scale for Patients with Type 2 Diabetes Mellitus. (One year, from December 2025 to December 2026)

Eligibility information

Inclusion Criteria: * Patients with T2DM 1. Who have been diagnosed with T2DM and meet the diagnostic criteria defined by the Chinese Guideline for the Prevention and Treatment of Diabetes (2024 Edition); 2. Aged ≥18 years; 3. Who volunteer to participate in this study. Healthcare workers: 1. Clinicians and nurses who have been engaged in medical care in the endocrine field for ≥5 years; 2. Who hold a Bachelor's degree or above and have an intermediate or above professional title. Exclusion Criteria: * Patients with T2DM: 1. Who have acute complications of T2DM or other serious life-threatening diseases that preclude cooperation with the study; 2. Who have cognitive impairment or are unable to communicate in writing or verbally Healthcare workers: 1. Who do not have direct contact with patients; 2. Who are currently undergoing standardized training or refresher programs.

Study locations

The Third Affiliated Hospital of Soochow University（THE FIRST PEOPLE'S HOSPITAL OF CHANGZHOU）, Changzhou, Jiangsu 213000 China

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.